Download PIERGIORGIO PETTAZZONI

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Protein moonlighting wikipedia , lookup

Apoptosis wikipedia , lookup

Cytosol wikipedia , lookup

Cell growth wikipedia , lookup

Cell cycle wikipedia , lookup

Cell encapsulation wikipedia , lookup

Mitosis wikipedia , lookup

Endomembrane system wikipedia , lookup

Cell culture wikipedia , lookup

Organ-on-a-chip wikipedia , lookup

Cytokinesis wikipedia , lookup

Extracellular matrix wikipedia , lookup

SULF1 wikipedia , lookup

Signal transduction wikipedia , lookup

Cellular differentiation wikipedia , lookup

Amitosis wikipedia , lookup

List of types of proteins wikipedia , lookup

Transcript
PIERGIORGIO PETTAZZONI
Relatore: Prof. Carlo Ferretti
Co-Relatore Dott.ssa Stefania Pizzimenti
Data di laurea: 17 luglio 2007
Titolo: 4-Hydroxynonenal (HNE)-protein adducts identification in HL-60 human lukemic cells
4-Hydoxynonenal (HNE), one of the most important aldheydic products generated from the lipidic
peroxidation of ω-6 polyunsaturated fatty acid, has been suggested to play a critical role in the
pathogenesis of various diseases, such as atherosclerosis, diabetes, Alzheimer and Parkinson
diseases. It has been demonstrated that HNE plays an important role in the control of tumour cell
proliferation and differentiation. One micromolar HNE, a dose similar to those detected in normal
cells, inhibits proliferation and induces differentiation of HL-60 human leukemic cells. This HNE
concentration also induces erythroid differentiation by increasing gamma globin expression in MEL
and K562 cells. Moreover, HNE causes cell cycle arrest and apoptosis in numerous cell lines. The
mechanism by which HNE causes these biological effects remains unclear but several studies
indicate that the ability of HNE to generate covalent adducts with cellular proteins may be directly
involved. HNE modifies proteins either by forming simple Michael adducts on lysine, histidine, and
cysteine residues or through Schiff base formation with lysine residues. Several studies have
already identified some HNE protein targets, such as metabolism enzymes, signal transduction
proteins, structural proteins, transporters and others.
The cytostatic effect of HNE on the HL-60 cell line has been well characterized in our laboratory.
After 1 micromolar HNE treatment, the expression of several genes controlling cellular
proliferation and differentiation is affected, such as c-myc, c-myb, cyclins and telomerase. The
identification of HNE-adducts in this well-characterized cell line represents a new insight in the
comprehension of molecular mechanisms elicited by HNE. However, the aim of this study was to
identify HNE-protein adducts after exposure of HL-60 cells to non citotoxic concentrations of
aldehyde. HL-60 represents a good model for HNE studies, since the lipid peroxidation process in
this cell line is very low, thus it is possible to identify the HNE adducts without the interference
caused by HNE endogenously produced.
For this study we used biochemical and proteomic techniques like western blotting, 2D
electrophoresis, MALDI/TOF mass spectrometry, immunoprecipitation, enzymatic assays ad
confocal microscopy imaging.
In the first part of our study we performed a series of western blots to choose the anti-HNE antibody
that shows the highest specificity for the evaluation of HNE-protein adducts.
Secondly, we have performed 2D electrophoresis to separate proteins, obtained by HNE-treated
cells. HNE-protein adducts were revealed after blotting on a PVDF membrane and by
immunochemical detection with the specific anti-HNE antibody, identified in the first part of our
study. Spots that reacted with the anti-HNE antibody were purified and analysed by MALDI/TOF
MS for their identification.
Our results showed the formation of HNE protein adducts with the glicolitic enzime α-enolase.
Immunoprecipitation analysis confirmed these results. This is the first evidence of the formation of
this HNE-protein adduct in tumor cells. HNE/α-enolase adduct formation doesn’t affect α-enolase
protein expression nor protein localisation. Nevertheless, enzymatic activity was reduced, but only
after exposure of the purified protein to high doses of HNE.
We also demonstrated the formation of HNE adducts with the c-myc binding protein-1 (MBP-1), an
alternative product of translation of α-enolase mRNA. MBP-1 is a negative regulator of c-myc
expression via interaction with the P2 promoter of the oncogene c-myc. The HNE/MBP-1 adducts
could be involved in c-myc down-regulation, a key event in HNE-caused cell proliferation arrest.
The use of confocal microscopy confirmed the co-localisation of enolase/HNE adducts in the
cytoplasm. Moreover, a diffuse nuclear fluorescence indicated the presence of several HNEadducts, that have to be characterized.
HNE/enolase and HNE/MBP-1 adducts are the first molecular targets indentified in the HL-60 cell
line, and this leads to new insights in the molecular mechanism of HNE-proliferation arrest.